Vishwas Seshadri's Insider Trades & SAST Disclosures
Vishwas Seshadri's most recent trade in Abeona Therapeutics Inc was a trade of 25,000 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Vishwas Seshadri.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.78 per share. | 31 Mar 2025 | 25,000 | 1,355,322 (1%) | 0% | 4.8 | 119,500 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 476,435 | 1,380,322 (1%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Seshadri Vishwas | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.54 per share. | 16 Oct 2024 | 251 | 903,887 (1%) | 0% | 6.5 | 1,642 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.89 per share. | 28 Sep 2024 | 18,798 | 904,138 (1%) | 0% | 5.9 | 110,720 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 424,000 | 922,936 (1%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 05 Jun 2024 | 38,621 | 498,936 (0%) | 0% | 4.5 | 174,567 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.38 per share. | 03 Jun 2024 | 703 | 537,557 (0%) | 0% | 4.4 | 3,079 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 25 Apr 2024 | 10,000 | 538,260 (0%) | 0% | 3.2 | 32,000 | Common Stock |
| Abeona Therapeutics Inc | Seshadri Vishwas | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.39 per share. | 06 Feb 2024 | 20,000 | 528,260 (0%) | 0% | 4.4 | 87,800 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 336,826 | 501,731 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.06 per share. | 02 Jun 2023 | 827 | 164,905 (0%) | 0% | 3.1 | 2,531 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.30 per share. | 17 Oct 2022 | 207 | 165,732 (0%) | 0% | 4.3 | 890 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2022 | 155,200 | 165,939 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.16 per share. | 01 Jun 2022 | 81,525 | 268,475 (0%) | 0% | 0.2 | 13,044 | Common Stock |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 50,000 | 350,000 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Vishwas Seshadri | SVP, Head of Res./Clin. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Vishwas Seshadri | SVP, Head of Res./Clin. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 200,000 | 200,000 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Vishwas Seshadri | SVP, Head of Res./Clin. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 100,000 | 300,000 (0%) | 0% | 0 | Common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges